Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications

Diabetes Metab Syndr Obes. 2020 Oct 9:13:3611-3616. doi: 10.2147/DMSO.S275898. eCollection 2020.

Abstract

Obesity is a triggering factor for diabetes associated with insulin resistance. In individuals who are obese, higher amounts of non-esterified fatty acids, glycerol, hormones, and pro-inflammatory cytokines that could participate in the development of insulin resistance are released by adipose tissue. Besides, endoplasmic reticulum stress, adipose tissue hypoxia, oxidative stress, lipodystrophy, and genetic background have a role in insulin resistance. However, no effective drug therapy was developed for type 2 diabetes mellitus targeting these physiological factors. This is might be due to a lack of agreement on the comprehensive mechanism of insulin resistance. Therefore, this review assesses the cellular components of each physiologic and pathophysiologic factors that are involved in obesity associated insulin resistance, and may encourage further drug development in this field.

Keywords: insulin; insulin resistance; obesity; type 2 diabetes mellitus.

Publication types

  • Review

Grants and funding

There is no funding to report.